FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316171257> ?p ?o ?g. }

• W4316171257 abstract "Currently, the standard treatment for locally advanced cervical cancer is concurrent chemoradiation (CCRT). Forty percent of patients present with disease recurrence. This study aims to investigate the feasibility, safety and efficacy of neoadjuvant chemotherapy (NACT) with weekly cisplatin and paclitaxel (TP) followed by CCRT.We are conducting a phase III trial comparing the efficacy and side effects of patients with cervical cancer (FIGO 2018 stage IIB to IVA) who were assigned to four cycles of NACT with cisplatin (40 mg/m2) and paclitaxel (60 mg/m2) weekly followed by CCRT or CCRT alone. In this report, we studied the medium-term effect of 50 patients enrolled in the NACT + CCRT arm. The primary endpoints were the response rate post-NACT and 12 weeks post-CCRT evaluated by MR/CT based on RECIST v 1.1. The secondary endpoints were 3-year OS (overall survival) and PFS (progression-free survival) measured by the Kaplan-Meier method.Among 50 patients enrolled in the NACT + CCRT arm, the complete and partial response rates were 10.4% and 68.8%, post-NACT. Twelve weeks after treatment completion, the complete response rate was 72.0%, whereas the total response rate (complete and partial response) was 90.0%. After a median follow-up of 28 months, the 3-year OS rate was 83.9%, and the 3-year PFS rate was 73.6%. NACT response was related to superior PFS and OS compared with NACT nonresponse (P < 0.01). Late AEs were exiguous, while early AEs mainly included myelosuppression and gastrointestinal AEs.This study showed a good response rate achieved by dose-dense weekly cisplatin and paclitaxel followed by standard CCRT. The treatment regimen is feasible, as evidenced by the acceptable toxicity of NACT and by the high compliance with radiotherapy.Protocol version number and date. Chinese clinical trial registry, ChiCTR1900025327; http://www.chictr.org.cn . Registered 24 August 2019. Retrospectively registered, medresman.org.cn/ChiCTR1900025326. The date recruitment began 01-01-2019." @default.
• W4316171257 created "2023-01-15" @default.
• W4316171257 creator A5002656825 @default.
• W4316171257 creator A5012677271 @default.
• W4316171257 creator A5013134577 @default.
• W4316171257 creator A5014486696 @default.
• W4316171257 creator A5015394635 @default.
• W4316171257 creator A5017193282 @default.
• W4316171257 creator A5018713975 @default.
• W4316171257 creator A5018740595 @default.
• W4316171257 creator A5040999059 @default.
• W4316171257 creator A5044751571 @default.
• W4316171257 creator A5048710370 @default.
• W4316171257 date "2023-01-14" @default.
• W4316171257 modified "2023-10-05" @default.
• W4316171257 title "Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer" @default.
• W4316171257 cites W1592737438 @default.
• W4316171257 cites W1977127004 @default.
• W4316171257 cites W2014166989 @default.
• W4316171257 cites W2019607817 @default.
• W4316171257 cites W2021200503 @default.
• W4316171257 cites W2029715376 @default.
• W4316171257 cites W2045598378 @default.
• W4316171257 cites W2060003507 @default.
• W4316171257 cites W2118508302 @default.
• W4316171257 cites W2126768246 @default.
• W4316171257 cites W2126834211 @default.
• W4316171257 cites W2133787749 @default.
• W4316171257 cites W2170091237 @default.
• W4316171257 cites W2190870061 @default.
• W4316171257 cites W2263001779 @default.
• W4316171257 cites W2284552871 @default.
• W4316171257 cites W2319132610 @default.
• W4316171257 cites W2417185998 @default.
• W4316171257 cites W2490081925 @default.
• W4316171257 cites W2511010656 @default.
• W4316171257 cites W2598381289 @default.
• W4316171257 cites W2605527739 @default.
• W4316171257 cites W2611332446 @default.
• W4316171257 cites W2621239205 @default.
• W4316171257 cites W2742133220 @default.
• W4316171257 cites W2786727643 @default.
• W4316171257 cites W2800129620 @default.
• W4316171257 cites W2889646458 @default.
• W4316171257 cites W2937537180 @default.
• W4316171257 cites W2971323891 @default.
• W4316171257 cites W2993250673 @default.
• W4316171257 cites W3083562457 @default.
• W4316171257 cites W3119124656 @default.
• W4316171257 cites W3200231835 @default.
• W4316171257 cites W4206029776 @default.
• W4316171257 cites W4298106286 @default.
• W4316171257 doi "https://doi.org/10.1186/s12885-023-10517-x" @default.
• W4316171257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36641433" @default.
• W4316171257 hasPublicationYear "2023" @default.
• W4316171257 type Work @default.
• W4316171257 citedByCount "1" @default.
• W4316171257 countsByYear W43161712572023 @default.
• W4316171257 crossrefType "journal-article" @default.
• W4316171257 hasAuthorship W4316171257A5002656825 @default.
• W4316171257 hasAuthorship W4316171257A5012677271 @default.
• W4316171257 hasAuthorship W4316171257A5013134577 @default.
• W4316171257 hasAuthorship W4316171257A5014486696 @default.
• W4316171257 hasAuthorship W4316171257A5015394635 @default.
• W4316171257 hasAuthorship W4316171257A5017193282 @default.
• W4316171257 hasAuthorship W4316171257A5018713975 @default.
• W4316171257 hasAuthorship W4316171257A5018740595 @default.
• W4316171257 hasAuthorship W4316171257A5040999059 @default.
• W4316171257 hasAuthorship W4316171257A5044751571 @default.
• W4316171257 hasAuthorship W4316171257A5048710370 @default.
• W4316171257 hasBestOaLocation W43161712571 @default.
• W4316171257 hasConcept C121608353 @default.
• W4316171257 hasConcept C126322002 @default.
• W4316171257 hasConcept C143998085 @default.
• W4316171257 hasConcept C146357865 @default.
• W4316171257 hasConcept C151730666 @default.
• W4316171257 hasConcept C203092338 @default.
• W4316171257 hasConcept C2776694085 @default.
• W4316171257 hasConcept C2777292972 @default.
• W4316171257 hasConcept C2778220009 @default.
• W4316171257 hasConcept C2778239845 @default.
• W4316171257 hasConcept C2779984678 @default.
• W4316171257 hasConcept C2780140570 @default.
• W4316171257 hasConcept C31760486 @default.
• W4316171257 hasConcept C535046627 @default.
• W4316171257 hasConcept C71924100 @default.
• W4316171257 hasConcept C86803240 @default.
• W4316171257 hasConceptScore W4316171257C121608353 @default.
• W4316171257 hasConceptScore W4316171257C126322002 @default.
• W4316171257 hasConceptScore W4316171257C143998085 @default.
• W4316171257 hasConceptScore W4316171257C146357865 @default.
• W4316171257 hasConceptScore W4316171257C151730666 @default.
• W4316171257 hasConceptScore W4316171257C203092338 @default.
• W4316171257 hasConceptScore W4316171257C2776694085 @default.
• W4316171257 hasConceptScore W4316171257C2777292972 @default.
• W4316171257 hasConceptScore W4316171257C2778220009 @default.
• W4316171257 hasConceptScore W4316171257C2778239845 @default.
• W4316171257 hasConceptScore W4316171257C2779984678 @default.
• W4316171257 hasConceptScore W4316171257C2780140570 @default.
• W4316171257 hasConceptScore W4316171257C31760486 @default.

• next